IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 735-743

  Yanaba, Koichi ^a   Yoshizaki, Ayumi ^b   Asano, Yoshihide ^c   Kadono, Takafumi ^c   Tedder, Thomas F ^d   Sato, Shinichi ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD1D ANTIGEN; CD5 ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INTESTINE INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY B10 CELL; WILD TYPE;

EID: 79951825006     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.022     Document Type: Article

References (43)

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205
2. Hibi T, Ogata H: Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006, 41:10-16
3. Sands BE: Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007, 42:16-25
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702 (Pubitemid 20069706)
5. Cooper HS, Murthy SN, Shah RS, Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249
6. Melgar S, Karlsson A, Michaelsson E: Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005, 288:G1328-G1338 (Pubitemid 40741088)
7. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW: Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000, 62:240-248
8. + T cell activation in mice. Proc Natl Acad Sci U S A 2007, 104:20882-20887
9. Xiu Y, Wong CP, Hamaguchi Y, Wang Y, Pop S, Tisch RM, Tedder TF: B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despite isotype-specific differences in FcγR effector functions. J Immunol 2008, 180:2863-2875
10. + T cells to protein antigens in vivo. J Immunol 1995, 155:3734-3741
11. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482
12. Linton PJ, Bautista B, Biederman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley LM: Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 2003, 197:875-883 (Pubitemid 36437864)
13. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF: CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 1996, 157:4371-4378 (Pubitemid 126449355)
14. Bouaziz JD, Yanaba K, Tedder TF: Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214
15. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650
16. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430
17. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK: Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med 1997, 186:1749-1756 (Pubitemid 27506287)
18. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230 (Pubitemid 34211962)
19. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274 (Pubitemid 23320290)
20. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995, 3:39-50
21. Wirtz S, Neufert C, Weigmann B, Neurath MF: Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007, 2:541-546 (Pubitemid 47040018)
22. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ: Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993, 38:1722-1734 (Pubitemid 23271431)
23. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, Oshel P, Bock CB, Miller AS, Albrecht RM, Kubes P, Steeber DA, Tedder TF: Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 2003, 19:713-724 (Pubitemid 37490796)
24. + T cells that secrete IFN-γ and IL-5. J Immunol 1990, 145:68-77
25. Meijerink J, Mandigers C, van de Locht L, Tonnissen E, Goodsaid F, Raemaekers J: A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative realtime PCR. J Mol Diag 2001, 3:55-61 (Pubitemid 32440243)
26. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF: The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009, 182:7459-7472
27. Haas KM, Poe JC, Steeber DA, Tedder TF: B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18 (Pubitemid 41019653)
28. Matsushita T, Horikawa M, Iwata Y, Tedder TF: Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and latephase immunopathogenesis. J Immunol 2010, 185:2240-2252
29. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK: Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 2000, 12:597-605 (Pubitemid 30248892)
30. αi2-deficient mice. Nat Genet 1995, 10:143-150
31. Hamm HE, Gilchrist A: Heterotrimeric G proteins. Curr Opin Cell Biol 1996, 8:189-196 (Pubitemid 26109092)
32. Hampe J, Lynch NJ, Daniels S, Bridger S, Macpherson AJ, Stokkers P, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S: Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut 2001, 48:191-197 (Pubitemid 32141842)
33. Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J: B cell developmental requirement for the Gαi2 gene. J Immunol 2003, 170:1707-1715 (Pubitemid 36197385)
34. Brummel R, Lenert P: Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005, 174:2429-2434 (Pubitemid 40223993)
35. + and CD5- B cells: possible involvement in age-associated cytokine dysregulation. Int Immunol 1997, 9:745-754
36. Shimomura Y, Mizoguchi E, Sugimoto K, Kibe R, Benno Y, Mizoguchi A, Bhan AK: Regulatory role of B-1 B cells in chronic colitis. Int Immunol 2008, 20:729-737 (Pubitemid 351791517)
37. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF: B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008, 223:284-299 (Pubitemid 351986191)
38. Hasegawa M, Hamaguchi Y, Yanaba K, Bouaziz J-D, Uchida J, Fujimoto M, Matsushita T, Matsushita Y, Horikawa M, Komura K, Takehara K, Sato S, Tedder TF: B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006, 169:954-966 (Pubitemid 44411958)
39. Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St. Clair EW, Tedder TF: B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007, 179:1369-1380
40. Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S: Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol 2006, 168:812-821 (Pubitemid 43327734)
41. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950 (Pubitemid 35154008)
42. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF: Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007, 13:1365-1368 (Pubitemid 350206846)
43. El Fassi D, Nielsen CH, Kjeldsen J, Clemmensen O, Hegedus L: Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut 2008, 57:714-715 (Pubitemid 351579988)